Elective stent-graft treatment of aortic dissections.

Department of Diagnostic Radiology and Research Institute of Radiological Science, Republic of Korea.
Journal of Endovascular Therapy (Impact Factor: 3.59). 01/2005; 11(6):667-75. DOI: 10.1583/1220MR.1
Source: PubMed

ABSTRACT To retrospectively review 8 years' experience with stent-graft treatment of aortic dissections at a single institution.
Forty-six patients (31 men; mean age 59 years, range 38-88) underwent stent-graft treatment for 9 Stanford type A and 37 type B aortic dissections (9 acute phase, 13 subacute, 24 chronic). Custom-designed self-expanding stainless steel Z stents covered with polytetrafluoroethylene were used (n=20) until low-profile modular stent-grafts became available for percutaneous delivery (n=26).
Endovascular stent-graft deployment was technically successful in 44 (96%) patients; the 2 failed cases owing to intraprocedural migration and graft torsion were converted to surgery. There were 5 type I endoleaks for a clinical success (entry tear exclusion) of 85% (39/46). Complications included 3 cases of transient renal failure, 2 puncture site pseudoaneurysms, 1 guidewire-induced new intimal tear (converted), and 2 cases of stent-induced saccular aneurysms (1 converted). Follow-up at a mean 34 months (range 12-96) showed complete resolution of the thoracic false lumen in 14 (74%) of 19 acute/subacute patients treated successfully; 3 (16%) showed a reduced thoracic false lumen diameter. In the 23 chronic-phase patients treated successfully, 8 (35%) had complete resolution of the thoracic false lumen, and 11 (48%) showed size reduction. Enlargement of the abdominal aortic false lumen due to persistent flow into re-entry tear(s) occurred in 3 (13%).
Stent-graft treatment is a feasible and effective treatment modality in aortic dissection. However, close follow-up is mandatory to monitor new intimal tear, saccular aneurysms, or enlargement of the abdominal aortic false lumen.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: To provide data regarding the etiology and timing of retrograde type A aortic dissection (RTAD) after thoracic endovascular aortic repair (TEVAR). Details of patients who had RTAD after TEVAR were obtained from the MOTHER Registry supplemented by data from a systematic review of the literature. Univariate analysis and binary logistic regression analysis of patient or technical factors was performed. In MOTHER, RTAD developed in 16 of the 1010 patients (1.6%). Binary logistic regression demonstrated that an indication of TEVAR for aortic dissection (acute P = 0.000212; chronic P = 0.006) and device oversizing (OR 1.14 per 1% increase in oversizing above 9%, P < 0.0001) were significantly more frequent in patients with RTAD. Data from the systematic review was pooled with MOTHER data and demonstrated that RTAD occurred in 1.7% (168/9894). Most of RTAD occurred in the immediate postoperative (58%) period and was associated with a high mortality rate (33.6%). The odds ratio of RTAD for an acute aortic dissection was 10.0 (CI: 4.7-21.9) and 3.4 (CI: 1.3-8.8) for chronic aortic dissection. The incidence of RTAD was not significantly different for endografts with proximal bare stent (2.8%) or nonbare stent (1.9%) (P = 0.1298). Although RTAD after TEVAR is an uncommon complication, it has a high mortality rate. RTAD is significantly more frequent in patients treated for acute and chronic type B dissection, and when the endograft is significantly oversized. The proximal endograft configuration was not associated with any difference in the incidence of RTAD.
    Annals of surgery 01/2014; · 7.19 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Zusammenfassung Die Entwicklung und der Einsatz endoluminaler Aortenprothesen haben insbesondere im Akutstadium mit Ruptur oder Endorganischämie das Therapiespektrum von Stanford-B-Dissektionen erweitert. Die bisherige alleinige offen-chirurgische Therapie ist die Aorten- Fensterungsoperation oder der primäre prothetische Aortenersatz zum Entry-Verschluss. Moderne bildgebende Schnittbildverfahren (CT oder MRT) mit 3D-Rekonstruktionen ermöglichen eine exakte präoperative Diagnostik und Planung einer chirurgischen Therapie, entweder offen oder endovaskulär. Die Therapieziele der endovaskulären Rekonstruktion ist der endoluminale Verschluss des proximalen Entrys, die darauffolgende Entfaltung des komprimierten wahren Lumens und die Induktion einer Thrombosierung des thorakalen Falschkanals. Dadurch soll eine Expansion des Falschkanals im Langzeitverlauf mit der Gefahr einer späteren Ruptur vermieden werden. Die endovaskuläre Implantationstechnik ist bei akuten und chronisch-expandierenden Aortendissektionen sehr anspruchsvoll und mit potentiellen Komplikationen behaftet. Das Konzept des endoluminalen Entry-Verschlusses bei akuter symptomatischer B-Dissektion ist dennoch vielversprechend und stellt eine Therapiealternative dar. Langzeitergebnisse der endovaskulären Therapie liegen bisher nicht vor. Die erforderlichen prospektiv-vergleichenden Studien werden zukünftig Klarheit bringen, sind aber durch die komplexe Morphologie und heterogene Population erschwert. Die Entwicklung einer speziellen Endoprothese zur Behandlung der akuten und chronischen Aortendissektion ist notwendig.
    Gefässchirurgie 08/2005; 10(4):293-313. · 0.24 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Objective: Questions regarding the specific patient/ disease that should be submitted to the endovascular procedur e still r emain unclear . The purpose of this study is to evaluate the endovascular treatment in chronic type B aortic dissections. Methods: Between 2003 and 2006, 1 1 patients with chr onic type B aortic dissection were submitted to endovascular pr ocedur e thr ough femoral ar ter y . All of them wer e monitored with CT within 6 months, at 1 year and afterwards annually . W e pr ospectively evaluated false lumen patency and thoracic and abdominal aortic diameters in each time point. The data comparisons wer e made using Anova and chi-square tests with SPSS 13. Results: The endovascular stent-graft deployment was technically successful for all patients, with no hospital mor tality . During the follow-up period, the false lumen flows remained persistent in the thorax in 27.3% of the patients and in the abdomen in 81,8%. However , in all patients, in both segments, the aorta diameter was not significantly changed in size and shape. Conclusion: Despite the small number of studied